We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway.
- Authors
S. Weidinger; A. Mayerhofer; L. Kunz; M. Albrecht; M. Sbornik; E. Wunn; R. Hollweck; J. Ring; F.M. Kohn
- Abstract
BACKGROUND: We previously localized protease-activated receptor 2 (PAR-2) on human spermatozoa and demonstrated that activation of PAR-2 by the mast cell (MC) product tryptase inhibits sperm motility. Importantly, tryptase-secreting MCs are encountered in the male and female genital tract, implying that MCspermatozoa interactions may be as yet unrecognized factors affecting sperm fertilizing ability. In order to elucidate how tryptase via activation of PAR-2 acts in human spermatozoa, we studied intracellular signal transduction events. METHODS AND RESULTS: Impairment of sperm motility by tryptase was not dependent on the presence of extracellular Ca2+ and tryptase did not alter intracellular Ca2+ levels. Pre-incubation with pertussis toxin (PTX) failed to prevent tryptase effects on sperm motility. Western blot analyses revealed that tryptase increased phosphorylation of the mitogen-activated protein kinases (MAPK) ERK1/2, an effect which was blocked by the MAPK pathway inhibitor PD98059. Pre-treatment of spermatozoa with this inhibitor also blocked the inhibtion of sperm motility evoked by tryptase. CONCLUSIONS: These results indicate that tryptase acts via the ERK1/2 pathway to inhibit motility of human spermatozoa.
- Publication
Human Reproduction, 2005, Vol 20, Issue 2, p456
- ISSN
0268-1161
- Publication type
Academic Journal
- DOI
10.1093/humrep/deh618